Tenon Medical, Inc. Announces Upcoming Virtual Conference Participation

Rhea-AI Summary

Tenon Medical (NASDAQ:TNON) announced its participation in upcoming virtual conferences, including the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022, and the A.G.P.'s Virtual MedTech Conference on September 21, 2022. CEO Steve Foster and CFO Steven Van Dick will be available for one-on-one meetings. Tenon Medical specializes in a proprietary, FDA-cleared surgical implant system aimed at optimizing SI Joint fixation/fusion surgery, with plans for a national launch to address market needs.

News Market Reaction – TNON

-3.69%

-3.69% Session move

In the trading session that priced this news, TNON declined 3.69%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOS GATOS, CA / ACCESSWIRE / August 24, 2022 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced its virtual participation in the following conferences:

• H.C. Wainwright 24^th Annual Global Investment Conference, September 12 - September 14, 2022
• A.G.P.'s Virtual MedTech Conference on September 21, 2022.

Steve Foster, CEO, and Steven Van Dick, CFO, will be available for one-on-one meetings. For more information about the events and to book a one-on-one meeting, please contact Tenon's Investor Relations at tenon@mzgroup.us.

About Tenon Medical, Inc.

Tenon Medical, Inc. (NASDAQ:TNON), a medical device company formed in 2012, has developed a proprietary, FDA cleared surgical implant system, which is designed to optimize SI-Joint fixation / fusion surgery and corresponding outcomes. Tenon is preparing a national launch of this system to address the greatly underserved market opportunity that exists in this space. For more information, please visit https://www.tenonmed.com/.

Investor Contact

Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.

View source version on accesswire.com:
https://www.accesswire.com/713353/Tenon-Medical-Inc-Announces-Upcoming-VirtualConference-Participation

FAQ

What conferences is Tenon Medical participating in September 2022?

Tenon Medical is participating in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022, and the A.G.P.'s Virtual MedTech Conference on September 21, 2022.

Who will represent Tenon Medical at the upcoming conferences?

CEO Steve Foster and CFO Steven Van Dick will represent Tenon Medical at the upcoming conferences.

What is Tenon Medical known for?

Tenon Medical is known for its proprietary, FDA-cleared surgical implant system for sacroiliac joint fixation/fusion surgery.

When was Tenon Medical established?

Tenon Medical was established in 2012.

How can I contact Tenon Medical for one-on-one meetings?

To schedule a one-on-one meeting with Tenon Medical, you can contact their Investor Relations at tenon@mzgroup.us.